Archive | Evercyte GmbH

Page 2 of 15
52357Evercyte assay-ready replicative senescent cells
Evercyte assay-ready replicative senescent cells Learn More >
Evercyte showcasing extracellular vesicle capabilities at GSEV/ASEV Autumn Meeting 2022
Evercyte showcasing extracellular vesicle capabilities at GSEV/ASEV Autumn Meeting 2022 Learn More >
Evercyte to present EV cell factory advances to Bioproduction Congress, Lyon
Evercyte to present EV cell factory advances to Bioproduction Congress, Lyon Learn More >
52002Evercyte human cells as in vitro test systems
Evercyte human cells as in vitro test systems Learn More >
Evercyte helps pioneer standardized production of spheroids for tissue engineering
Evercyte helps pioneer standardized production of spheroids for tissue engineering Learn More >
Evercyte standardized fibrosis assays to screen drugs and EVs
Evercyte standardized fibrosis assays to screen drugs and EVs Learn More >
Evercyte showcasing latest extracellular vesicle ‘cell factories’ and revolutionary CD81 targeting at ISEV 2022 Lyon
Evercyte showcasing latest extracellular vesicle ‘cell factories’ and revolutionary CD81 targeting at ISEV 2022 Lyon Learn More >
Evercyte bringing EV partnership opportunities to BIO-Europe Spring online summit
Evercyte bringing EV partnership opportunities to BIO-Europe Spring online summit Learn More >
51201Evercyte Extracellular Vesicle (EV) Potency Testing
Evercyte Extracellular Vesicle (EV) Potency Testing Learn More >
Senolytic Drug Testing using cell-based assays
Senolytic Drug Testing using cell-based assays Learn More >
Evercyte adds placenta/amnion derived MSCs to its ‘cell factory’ lines
Evercyte adds placenta/amnion derived MSCs to its ‘cell factory’ lines Learn More >
Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influences
Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influences Learn More >
Page 2 of 15